E
uropean
S
ociety of
T
oxicologic
P
athology
Publications
Useful Links
Calendar
Open Positions
For Employers
Next Generation
Home & News
ESTP Meetings
Guess What!
Organization
Members Only
Guidelines
Nomenclature
ESTP Congress 2005: Case No 4
case index
|
<< previous case
|
next case >>
Digital slide:
Case 4-1:
Mesenteric lymph node, H&E, Treated: cyclophosphamide 3 mg/kg
Case 4-2:
Peyer's patches, H&E, Treated: cyclophosphamide 3 mg/kg
Case 4-3:
Spleen, B lymphocytes, Control
Case 4-4:
Spleen, T lymphocytes, Control
Case 4-5:
Spleen, B lymphocytes, Treated: cyclophosphamide 6 mg/kg
Case 4-6:
Spleen, T lymphocytes, Treated: cyclophosphamide 6 mg/kg
Case 4-7:
Mesenteric lymph node, B lymphocytes, Treated: cyclophosphamide 6 mg/kg
Case 4-8:
Peyer's patches, B lymphocytes, Treated: cyclophosphamide 6 mg/kg
Species / breed:
Rat
Sex:
Male and female
Age:
10 weeks
Study type:
2-week repeated dose
Treatment:
Cyclophosphamide
Clinical findings:
None
Organ(s):
Bone marrow, mesenteric lymph nodes, Peyer's patches, spleen
Gross finding(s):
Small spleen in high dosed group (6mg/kg)
Staining:
H&E, B- and T-lymphocytes
case index
|
<< previous case
|
next case >>